Masayuki Amagai Selected Research

Immunoglobulins (Immunoglobulin)

5/2014	Dual role of interleukin-23 in epicutaneously-sensitized asthma in mice.
3/2010	Immune dysregulation of pemphigus in humans and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Amagai Research Topics

Disease

95	Pemphigus (Pemphigus Vulgaris) 04/2024 - 01/2002
37	Blister (Bulla) 01/2022 - 05/2002
18	Atopic Dermatitis (Atopic Eczema) 12/2023 - 12/2007
17	Skin Diseases (Skin Disease) 04/2024 - 02/2003
15	Neoplasms (Cancer) 10/2023 - 09/2008
13	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 09/2002
12	Dermatitis 04/2024 - 05/2010
11	Inflammation (Inflammations) 04/2024 - 05/2009
11	Acantholysis 04/2024 - 01/2002
9	Bullous Pemphigoid (Pemphigoid) 12/2021 - 12/2002
9	Impetigo (Impetigo Contagiosa) 03/2012 - 05/2002
9	Staphylococcal Scalded Skin Syndrome (Ritter's Disease) 03/2012 - 05/2002
7	Melanoma (Melanoma, Malignant) 12/2021 - 01/2015
5	Disease Progression 01/2022 - 05/2012
4	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 12/2021 - 06/2011
4	Infections 01/2021 - 02/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020 - 11/2006
4	Eczema 04/2015 - 05/2009
4	Asthma (Bronchial Asthma) 05/2014 - 08/2008
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 09/2003
3	Ulcerative Colitis 01/2023 - 08/2003
3	Fever (Fevers) 08/2022 - 06/2018
3	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 07/2017 - 03/2012
3	Contact Dermatitis (Eczema, Contact) 11/2015 - 05/2010
3	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 01/2011 - 08/2008
2	Porokeratosis (Palmoplantar Porokeratosis) 04/2024 - 12/2019
2	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 04/2024 - 09/2010
2	Erythema 03/2024 - 08/2022
2	Extramammary Paget Disease (Paget Disease, Extramammary) 10/2023 - 04/2020
2	Rheumatoid Arthritis 01/2023 - 02/2014
2	Erythema Multiforme 01/2023 - 07/2017
2	Ichthyosis (Xeroderma) 11/2022 - 02/2013
2	Annular Erythema 10/2021 - 05/2004
2	Rare Diseases (Rare Disease) 09/2021 - 09/2010
2	Linear IgA Bullous Dermatosis 09/2021 - 01/2018
2	Anaphylaxis (Anaphylactic Shock) 12/2020 - 10/2012
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2015
2	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2018 - 04/2015
2	Epidermolysis Bullosa 01/2018 - 10/2007

Drug/Important Bio-Agent (IBA)

66	AutoantibodiesIBA 04/2024 - 01/2002
61	Immunoglobulin G (IgG)IBA 02/2023 - 01/2002
45	Desmoglein 3IBA 06/2023 - 01/2002
39	DesmogleinsIBA 10/2023 - 09/2002
27	AntibodiesIBA 12/2021 - 01/2002
23	AntigensIBA 04/2024 - 09/2002
20	Desmoglein 1IBA 01/2019 - 01/2002
19	Proteins (Proteins, Gene)FDA Link 09/2022 - 07/2002
15	AutoantigensIBA 12/2021 - 09/2002
15	EpitopesIBA 07/2015 - 02/2003
11	EnzymesIBA 01/2022 - 01/2002
11	Filaggrin ProteinsIBA 11/2021 - 08/2008
11	Cadherins (E-Cadherin)IBA 01/2012 - 05/2002
10	Monoclonal AntibodiesIBA 10/2020 - 02/2003
8	ImmunosorbentsIBA 11/2013 - 01/2002
8	ExfoliatinsIBA 03/2012 - 05/2002
7	Immunoglobulin A (IgA)IBA 04/2024 - 01/2002
6	Immunoglobulin E (IgE)IBA 12/2021 - 05/2009
5	Nonsense Codon (Nonsense Mutation)IBA 08/2021 - 08/2008
5	Protein Isoforms (Isoforms)IBA 05/2017 - 08/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 10/2011
4	CytokinesIBA 06/2023 - 05/2014
4	Rituximab (Mabthera)FDA Link 02/2023 - 07/2017
4	Collagen Type VIIIBA 01/2018 - 10/2007
4	Desmosomal CadherinsIBA 01/2018 - 10/2002
4	Cell Adhesion MoleculesIBA 01/2018 - 02/2003
4	SteroidsIBA 02/2017 - 02/2009
4	HaptensIBA 11/2015 - 05/2010
3	Interleukin-17 (Interleukin 17)IBA 04/2024 - 09/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 04/2015
3	Immunoglobulin M (IgM)IBA 01/2022 - 10/2004
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 04/2009
3	Immune Checkpoint InhibitorsIBA 08/2021 - 01/2019
3	NivolumabIBA 10/2020 - 11/2016
3	Peptides (Polypeptides)IBA 01/2017 - 02/2004
3	Keratins (Keratin)IBA 09/2015 - 05/2004
3	Prednisolone (Predate)FDA LinkGeneric 03/2013 - 10/2005
3	Glycoproteins (Glycoprotein)IBA 03/2012 - 12/2003
2	Mevalonic Acid (Mevalonate)IBA 04/2024 - 12/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 03/2009
2	Formaldehyde (Formol)FDA Link 12/2023 - 09/2015
2	Oxygen (Dioxygen)IBA 11/2023 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 02/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023 - 05/2014
2	LipidsIBA 11/2022 - 09/2022
2	Interleukin-4 (Interleukin 4)IBA 09/2022 - 01/2022
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2021 - 09/2003
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2021 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 11/2008
2	ChemokinesIBA 08/2021 - 01/2011
2	NucleotidesIBA 02/2021 - 04/2015
2	DesmocollinsIBA 10/2020 - 12/2010
2	InterleukinsIBA 06/2018 - 05/2014
2	Vancomycin FDA LinkGeneric 01/2018 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 02/2014

Therapy/Procedure

24	Therapeutics 05/2024 - 04/2003
4	Drug Therapy (Chemotherapy) 03/2020 - 09/2013
2	Precision Medicine 12/2023 - 12/2020
2	Stem Cell Transplantation 03/2019 - 10/2005
2	Transplantation 01/2018 - 10/2012